TETRAGENEX PHARMACEUTICALS, INC.
TETRAGENEX PHARMACEUTICALS, INC. (TTRX) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 17 transactions totaling $315.4K, demonstrating a bullish sentiment with $315.4K in net insider flow. The most recent transaction on Jan 7, 2026 involved a transaction of 21,882 shares valued at $0.
TTRX Insider Activity Summary
Who Is Buying TTRX Stock?
No significant insider buying has been recorded for TTRX in the recent period.
Who Is Selling TTRX Stock?
No significant insider selling has been recorded for TTRX in the recent period.
Is TETRAGENEX PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TTRX is bullish with an Insider Alignment Score of 100/100 and a net flow of $315.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TTRX Frequently Asked Questions
Understanding TTRX Insider Activity
Insider trading at TETRAGENEX PHARMACEUTICALS, INC. (TTRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading TTRX stock, having executed 17 transactions in the past 90 days. The most active insider is Arthur F. Golden (Executive), who has made 4 transactions totaling $192.9K.
Related Tools
Track TETRAGENEX PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at TTRX file new Form 4 transactions